BioHarvest Sciences Inc.
CNVCF
$0.19
-$0.01-5.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 180.02% | 204.84% | 179.82% | 161.56% | 131.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 180.02% | 204.84% | 179.82% | 161.56% | 131.58% |
| Cost of Revenue | 122.71% | 179.19% | 197.39% | 198.81% | 159.79% |
| Gross Profit | 385.58% | 278.91% | 140.10% | 81.94% | 66.67% |
| SG&A Expenses | 72.97% | 94.30% | 88.68% | 89.25% | -16.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.56% | 66.71% | 53.57% | 52.08% | 15.20% |
| Operating Income | -7.51% | -21.85% | -18.24% | -24.98% | 4.43% |
| Income Before Tax | 20.11% | -11.06% | -91.49% | -14.34% | 8.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.11% | -11.06% | -91.49% | -14.34% | 8.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.11% | -11.06% | -91.49% | -14.34% | 8.85% |
| EBIT | -7.51% | -21.85% | -18.24% | -24.98% | 4.43% |
| EBITDA | -6.14% | -20.51% | -15.35% | -21.85% | 7.45% |
| EPS Basic | 20.98% | -8.65% | -88.70% | -8.30% | 14.83% |
| Normalized Basic EPS | 21.43% | -8.46% | -91.55% | -8.39% | 14.63% |
| EPS Diluted | 20.98% | -8.65% | -88.70% | -8.30% | 14.83% |
| Normalized Diluted EPS | 21.43% | -8.46% | -91.55% | -8.39% | 14.63% |
| Average Basic Shares Outstanding | 1.64% | 2.33% | 2.80% | 4.00% | 6.34% |
| Average Diluted Shares Outstanding | 1.64% | 2.33% | 2.80% | 4.00% | 6.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
